ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
51 announcements with these filters
Anlon Healthcare's board approved incorporation of two subsidiaries, investing up to Rs 1.75 million (₹0.175 Crore). The company will hold 55% and 65% equity respectively.
Anlon Healthcare Ltd reported revenue from operations of ₹33.3 Cr (-11.9% YoY) and net profit of ₹3.5 Cr (-7.9% YoY) for Q1 FY26.
Anlon Healthcare's Chairman and Managing Director participated in a media interview on Money TV. The discussion focused on FY 2025-26 performance and industry outlook.
Anlon Healthcare Limited reported FY26 consolidated total income of ₹172.22 Cr, up 42.98% YoY. Strategy focuses on API expansion and CDMO scaling.
Anlon Healthcare reports strong FY26 growth with revenues reaching ₹171.97cr, up from ₹120.29cr in FY25. Strategy focuses on backward integration and expansion via Bizotic and Apiqo acquisitions.
Anlon Healthcare reported FY26 consolidated revenue of ₹172.22 Crore, a 43% year-on-year increase. PAT grew 42% to ₹29.09 Crore, driven by strategic acquisitions and API demand.
Anlon Healthcare Ltd reported revenue from operations of ₹50.9 Cr (+4.1% YoY) and net profit of ₹11.1 Cr (-33.1% YoY) for Q4 FY26.
Anlon Healthcare approved audited FY26 financial results showing standalone total income of ₹176.75 Crore. The board also reviewed issue proceeds utilization and audit reports.
Anlon Healthcare Limited scheduled a board meeting for May 29, 2026. The board will consider audited standalone and consolidated financial results for fiscal year 2026.
Anlon Healthcare Limited reported the full utilization of its ₹121.03 Crore IPO proceeds. The report confirms alignment with shareholder-approved objects including facility expansion and acquisitions.
Anlon Healthcare completed the 63.98% equity acquisition of Remember India Health Links Private Limited. The target company now operates as a subsidiary of the firm.
Anlon Healthcare Limited has allotted 26,57,57,500 bonus equity shares of Rs. 2/- each in a 1:1 ratio to eligible shareholders. This allotment increases the company's paid-up equity share capital to Rs. 106.30 Crore, divided into 53,15,15,000 equity shares.
Anlon Healthcare Limited announced a new ISIN (INE0Y8W01025) following the sub-division of one equity share (face value Rs. 10) into five shares (face value Rs. 2). The change takes effect on the record date, April 24, 2026, after receiving activation confirmations from NSDL and CDSL.
Anlon Healthcare Limited signed an SPA to acquire a 63.98% stake in Remember India Health Links Private Limited for ₹5.38 Crore. The acquisition facilitates the company's transition from an API manufacturer to a complete pharmaceutical provider. The transaction is expected to conclude within 4-5 months.
Anlon Healthcare Limited approved the acquisition of a 63.98% stake in Remember India Health Links Private Limited for ₹5.38 Crore. This strategic move enables the company to expand from API manufacturing into finished dosage formulations. The transaction is expected to conclude within five months, making the target company a subsidiary.
Anlon Healthcare Ltd disclosed that it does not fall under the 'Large Corporate' category as of March 31, 2026, per SEBI norms. The company reported outstanding long-term borrowings of ₹27.00 Crore, which is below the ₹100 Crore threshold required for such identification.
Anlon Healthcare Limited announced that Brickwork Ratings has reaffirmed and subsequently withdrawn the credit ratings for its ₹34.86 Crore bank facilities. The withdrawal follows the closure of term loan facilities and a request from the company. Consequently, the previous rating rationale no longer reflects the company's current financial position.
Anlon Healthcare Limited has submitted its Structured Digital Database (SDD) compliance certificate for the quarter ended March 31, 2026. The certificate, issued by K. P. Ghelani & Associates, confirms the company maintains a non-tamperable database to track unpublished price-sensitive information (UPSI) as per SEBI regulations.
Anlon Healthcare Limited shareholders approved a sub-division of equity shares from ₹10 to ₹2 face value and an increase in authorized share capital from ₹55 Crore to ₹110 Crore via postal ballot on April 08, 2026. The Memorandum of Association has been amended accordingly.
Anlon Healthcare Limited has fixed April 24, 2026, as the record date for a 1:1 bonus share issue and a stock split from Rs. 10 to Rs. 2 face value. These actions aim to reward shareholders and enhance liquidity.
Anlon Healthcare shareholders approved a 1:5 stock split, a bonus share issue, and an increase in authorized share capital via postal ballot. All resolutions passed with a requisite majority. These actions aim to improve liquidity and reward existing shareholders.